Healthcare SPDR, Biotechs, Medical Devices, Healthcare Providers Take the Lead

SPY and QQQ are holding up well, but the S&P 500 EW ETF took a hit and breadth continued to deteriorate. SPY remains well above its rising 200-day SMA and within 2% of a 52-wk high. RSP, in contrast, fell around 4.5% in September and is within 2% of its 200-day SMA. Both are still in uptrends with RSP at a moment of truth. Breadth continued its deterioration with SPX %Above 200-day SMA falling to